RefinedPractice
19th Annual Lecture: What Constitutes Credible Evidence of Effectiveness?
4 June 2013
Since 1993, OHE has hosted an annual lecture given by an eminent economist or clinician on an important current issue. In 2012, Professor Sir Michael Rawlins…
OHE’s Towse on Challenges in Valuing Genomic Medicines
23 May 2013
In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” — those medicines that…
Contracting for Quality in the NHS is the Topic of OHE’s 20th Annual Lecture
20 May 2013
Professor Alan Maynard of the University of York, who will speak on Contracting for Quality in the NHS: Putting the Francis Report in Perspective.
Exploring the Link Between Health and Wealth in Government Decision Making
16 May 2013
Traditionally, decision makers both within and outside the health sector have thought of the value of health interventions primarily in terms of reduced morbidity or mortality.…
OHE’s Adrian Towse is ISPOR President-Elect for 2013-14
13 May 2013
OHE’s Director, Professor Adrian Towse, has been elected President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for the 2014–15 term and will serve…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
OHE has just released a research paper that describes an experimental study intended to test whether and how a multi-criteria decision analysis (MCDA) approach can be…
OHE Welcomes Professors Rawlins and Smith to its Policy Board
6 May 2013
Composed of academics and thought leaders from within and outside of the UK, OHE’s Policy Board has provided advice and guidance to the OHE on its…
NICE Decisions: Exploring the Influence of Cost-Effectiveness and Other Factors
30 April 2013
OHE presents a series of lunchtime seminars throughout the year. The most recent seminar, held in late April, considered the influence of cost-effectiveness and other factors…
OHE’s Towse on Quality Standards in the ‘New’ English NHS
29 April 2013
The 2013 conference of the Association of the British Pharmaceutical Industry (ABPI) addressed the challenges and opportunities presented by the recent changes in the NHS. Understanding…